Where does Takeda Vaccines, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Takeda Vaccines, Inc. ranks #5,249 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Takeda Vaccines, Inc. hold?

Takeda Vaccines, Inc. holds 66 US utility patents granted between 2015 and 2025, spanning 10 technology areas.

What is Takeda Vaccines, Inc.'s Innovation Score?

Takeda Vaccines, Inc. has an Innovation Score of 45.1 out of 100 (top 24% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Takeda Vaccines, Inc.'s patent grant rate increasing or decreasing?

Takeda Vaccines, Inc.'s recent grant velocity is -3% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Takeda Vaccines, Inc.'s patents?

Takeda Vaccines, Inc.'s patents average 22.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Takeda Vaccines, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Takeda Vaccines, Inc.

Q: What technology areas does Takeda Vaccines, Inc. focus on?

Takeda Vaccines, Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 65 patents, ranking #153 of 4,144 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 66 granted patents across 10 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Takeda ranks #5,249 of 49,997 tracked US assignees by granted-patent volume, with 66 patents across 10 technology areas.

#5,249
of 49,997 US assignees by volume: Top 24%
by Innovation Score (45.1/100): 22.9
avg claims per patent: -3%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5249 · US Corporation #5,249 · 66 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 66 grants
UPPER-Q #5,249/49,997
PHOTO-FINISH Superior Industries
CPC-FOCUS C12N · 10 areas
INNOV-PAR 45.1/100
CLAIMS-DENSE 22.9 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT -3% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Superior Industries, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Takeda’s 45.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.5 pts (32%) Velocity 5.7 pts (13%) Breadth 11.2 pts (25%) Claim depth 13.8 pts (31%)

Qualcomm Incorporated · highest

85
FSP Technology · near

45
British Telecommunic… · near

45
DB HiTek · near

45
Takeda Vaccines · this assignee

45
Shenzhen Neewer… · near

45
3D Lighting… · lowest

7

What this shows Takeda's Innovation Score is 45.1/100 (top 24% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Takeda?

Each dot is one of Takeda’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Takeda’s own 22.9 claims/patent is ABOVE the 15.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Takeda vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Takeda's grants concentrate

Takeda Vaccines, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 98.5% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2018 (9 grants) versus a trough of 4 in 2022. By volume, Takeda sits between Superior Industries, Inc. and Urschel Laboratories, Inc..

Takeda's three-year grant acceleration

From 2019–2021 to 2022–2024, Takeda Vaccines, Inc. moved from 20 to 17 grants (0.85x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Superior Industri…

66
Tekelec

66
TPK Advanced Solu…

66
Trek Bicycle

66
Theranos IP

66
Toast

66
University of Pue…

66
Urschel Laborator…

66
Takeda Vaccines ◀

66

What this shows Takeda holds 66 patents at rank #5,252, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Takeda

By rank, the assignees closest to #5,252 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Takeda's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Takeda, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Takeda ranks #153 of 4,144 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (45 here).

British Telecommunications PLC 45 DB HiTek Co., Ltd. 45 FSP Technology Inc. 45 Shenzhen Neewer Technology Co. Ltd 45

Similar claim depth

Nearest assignees by average claims per patent (22.9 here).

Ionis Pharmaceuticals, Inc. 22.9 avg Bioverativ Therapeutics Inc. 23.0 avg Location Labs, Inc. 23.0 avg Markforged, Inc 23.0 avg

Takeda's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 24% higher than 76% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Takeda Vaccines, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	6	9.1%
2016	6	9.1%
2017	5	7.6%
2018	9	13.6%
2019	6	9.1%
2020	8	12.1%
2021	6	9.1%
2022	4	6.1%
2023	6	9.1%
2024	7	10.6%
2025partial year	3	4.5%

Which technologies does Takeda Vaccines, Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 65

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 60

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 57

Y02A - Technologies FOR Adaptation TO Climate Change 34

C07K - Peptides 28

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 6

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 2

C08L - Compositions OF Macromolecular Compounds 2

C12Y - Enzymes 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Takeda Vaccines, Inc.'s patent record in context - here's where to go next.

Takeda Vaccines, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 98.5% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #5,249 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Takeda Vaccines, Inc. against Superior Industries, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 45.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.